HemoBioTech and Its Innovative Blood Substitute HemoTech Could Benefit From House Resolution to Support Small Biotechnology Companies
25 mars 2010 08h00 HE | HemoBioTech
DALLAS, TX--(Marketwire - March 25, 2010) -  Congressman Danny K. Davis (Il-7th) recently submitted House Resolution 1179, legislation that puts Congress on record in supporting biotechnology...
HemoBioTech Gains Congressional Recognition of Its Blood Substitute Technology
17 août 2009 08h38 HE | HemoBiotech
DALLAS, TX--(Marketwire - August 17, 2009) - HemoBioTech, Inc. (OTCBB: HMBT) has been working with a coalition of small biotechnology firms to implement legislation that will strengthen the Federal...